We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-13.65%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.62B
AUM Growth
-$585M
(-18%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
5.7%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
74
New
4
Increased
19
Reduced
26
Closed
3
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$86.5M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$59.5M |
| 3 |
Xenon Pharmaceuticals
XENE
|
+$49.6M |
| 4 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
+$24.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$23.9M |
Top Sells
| 1 |
argenx
ARGX
|
+$41.9M |
| 2 |
UnitedHealth
UNH
|
+$27.3M |
| 3 |
LivaNova
LIVN
|
+$24.6M |
| 4 |
ICU Medical
ICUI
|
+$21.6M |
| 5 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$10.8M |
Sector Composition
| 1 | Healthcare | 96.11% |
| 2 | Consumer Staples | 2.55% |
| 3 | Industrials | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$336M
| $321M | 12.26% |
12,957,222
| – | – |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $238M | 9.09% |
22,158,891
-170,495
| -0.8% | -$1.4M |
|
|
SGEN
3
DELISTED
Seagen Inc. Common Stock
SGEN
| $151M | 5.77% |
854,013
+412,739
| +94% | +$59.5M |
|
|
4
argenx
ARGX
$54.1B
| $146M | 5.58% |
385,818
-130,125
| -25% | -$41.9M |
|
5
Krystal Biotech
KRYS
$10.2B
| $125M | 4.76% |
1,898,545
+82,847
| +5% | +$5.15M |
|
|
6
LivaNova
LIVN
$4.4B
| $101M | 3.87% |
1,623,762
-346,749
| -18% | -$24.6M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $72.8M | 2.78% |
+913,319
| New | +$86.5M |
|
8
Beam Therapeutics
BEAM
$3.13B
| $71.6M | 2.73% |
1,849,887
+13,837
| +0.8% | +$550K |
|
9
SkinHealth Systems
SKIN
$118M
| $66.7M | 2.55% |
5,186,348
-118,157
| -2% | -$1.58M |
|
10
Replimune Group
REPL
$824M
| $63.7M | 2.43% |
3,645,309
-46,003
| -1% | -$756K |
|
|
IGMS
11
DELISTED
IGM Biosciences
IGMS
| $60.1M | 2.3% |
3,334,355
| – | – |
|
12
ADC Therapeutics
ADCT
$158M
| $59.7M | 2.28% |
7,512,029
+79,600
| +1% | +$753K |
|
13
Celldex Therapeutics
CLDX
$3.01B
| $55.8M | 2.13% |
2,070,288
+24,019
| +1% | +$698K |
|
14
Centene
CNC
$33B
| $55.1M | 2.1% |
651,447
+2,610
| +0.4% | +$217K |
|
15
Kymera Therapeutics
KYMR
$9.3B
| $51.3M | 1.96% |
2,607,130
-7,900
| -0.3% | -$185K |
|
|
16
Xenon Pharmaceuticals
XENE
$6.52B
| $49.9M | 1.9% |
+1,639,344
| New | +$49.6M |
|
17
Regenxbio
RGNX
$622M
| $49.5M | 1.89% |
2,004,663
+27,740
| +1% | +$693K |
|
18
Atara Biotherapeutics
ATRA
$76.3M
| $48.6M | 1.86% |
249,710
-126
| -0.1% | -$20.6K |
|
|
IMGN
19
DELISTED
Immunogen Inc
IMGN
| $41.1M | 1.57% |
9,141,045
-76,900
| -0.8% | -$334K |
|
20
Elevance Health
ELV
$84.6B
| $40.5M | 1.55% |
83,987
+825
| +1% | +$408K |
|
|
SNCE
21
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $39.8M | 1.52% |
990,412
| – | – |
|
|
MDVL
22
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $38.5M | 1.47% |
503,855
+282,353
| +127% | +$24.8M |
|
23
Nurix Therapeutics
NRIX
$2.45B
| $38.1M | 1.45% |
3,006,684
-12,100
| -0.4% | -$137K |
|
|
RPTX
24
DELISTED
Repare Therapeutics
RPTX
| $38.1M | 1.45% |
2,720,996
-12,000
| -0.4% | -$141K |
|
|
ONEM
25
DELISTED
1Life Healthcare
ONEM
| $35.5M | 1.35% |
4,521,825
+1,116,990
| +33% | +$9.6M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO